Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

Machtay, 2003, Complex and controversial issues in locally advanced non-small cell lung carcinoma, Semin Surg Oncol, 21, 128, 10.1002/ssu.10030

Gridelli, 2003, Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents, Oncogene, 22, 6629, 10.1038/sj.onc.1206957

Kerr, 1994, Apoptosis: its significance in cancer and cancer therapy, Cancer, 73, 2013, 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J

LaCasse, 1998, The inhibitors of apoptosis (IAPs) and their emerging role in cancer, Oncogene, 17, 3247, 10.1038/sj.onc.1202569

Deveraux, 1999, IAP family proteins-suppressors of apoptosis, Genes Dev, 13, 239, 10.1101/gad.13.3.239

Li, 1998, Control of apoptosis and mitotic spindle checkpoint by survivin, Nature, 396, 580, 10.1038/25141

Mahotka, 1999, Survivin-delta Ex3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties, Cancer Res, 59, 6097

Rodriguez, 2002, CRM1-mediated nuclear export determines the cytoplasmic localization of the anti-apoptotic protein Survivin, Exp Cell Res, 275, 44, 10.1006/excr.2002.5492

Ambrosini, 1997, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat Med, 3, 917, 10.1038/nm0897-917

Adida, 1998, Anti-apoptosis gene survivin and prognosis of neuroblastoma, Lancet, 351, 882, 10.1016/S0140-6736(05)70294-4

Kawasaki, 1998, Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer, Cancer Res, 58, 5071

Kappler, 2001, Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients, Int J Cancer, 95, 360

Zaffaroni, 2002, Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer, Cell Mol Life Sci, 59, 1406, 10.1007/s00018-002-8518-3

Kato, 2001, Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy, Int J Cancer, 95, 92, 10.1002/1097-0215(20010320)95:2<92::AID-IJC1016>3.0.CO;2-9

Asanuma, 2000, Survivin as a radioresistance factor in pancreatic cancer, Jpn J Cancer Res, 91, 1204, 10.1111/j.1349-7006.2000.tb00906.x

Trieb, 2003, Survivin expression in human osteosarcoma is a marker for survival, Eur J Surg Oncol, 29, 379, 10.1053/ejso.2002.1415

Lehner, 2002, Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma, Appl Immunohistochem Mol Morphol, 10, 134, 10.1097/00129039-200206000-00007

Okada, 2001, Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients, Cancer Lett, 163, 109, 10.1016/S0304-3835(00)00677-7

Kennedy, 2003, Prognostic importance of survivin in breast cancer, Br J Cancer, 88, 1077, 10.1038/sj.bjc.6600776

Monzò, 1999, A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers, J Clin Oncol, 17, 2100, 10.1200/JCO.1999.17.7.2100

Ikehara, 2002, Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small cell adenocarcinoma of the lung, Oncol Rep, 9, 835

Falleni, 2003, Survivin gene expression in early-stage non-small cell lung cancer, J Pathol, 200, 620, 10.1002/path.1388

Miller, 1981, Reporting results of cancer treatment, Cancer, 47, 207, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6

Mountain, 1997, Revisions in the International System for Staging Lung Cancer, Chest, 111, 1710, 10.1378/chest.111.6.1710

Ferreira, 2001, Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small cell lung cancer patients, Ann Oncol, 12, 799, 10.1023/A:1011167113067

Grabowski, 2003, Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma, Br J Cancer, 88, 115, 10.1038/sj.bjc.6600696

Altman, 1994, Dangers of using “optimal” cutpoints in the evaluation of prognostic factors, J Natl Cancer Inst, 86, 829, 10.1093/jnci/86.11.829

Altieri, 2001, The molecular basis and potential role of survivin in cancer diagnosis and therapy, Trends Mol Med, 7, 542, 10.1016/S1471-4914(01)02243-2

Fortugno, 2002, Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function, J Cell Sci, 115, 575, 10.1242/jcs.115.3.575

Ferreira, 2001, Expression of XIAP (X-linked inhibitor of apoptosis) as novel prognostic marker in radically resected non-small cell lung cancer patients, Clin Cancer Res, 7, 2468

Altieri, 2003, Survivin, versatile modulation of cell division and apoptosis in cancer, Oncogene, 22, 8581, 10.1038/sj.onc.1207113